3 Strong Reasons To Buy Aviva plc Today

Aviva plc (LON:AV) has performed well this year but could be due a further re-rating, says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Over the last five years, Aviva (LSE: AV) (NYSE: AV.US) has disappointed investors and underperformed the market, falling by 25%, while the FTSE 100 has gained 21%.

However, recent months have seen Aviva’s new management, led by CEO Mark Wilson, take concrete steps to turn the company around and place it on a solid financial footing. Aviva’s share price has risen by 11.5% so far this year, matching the FTSE, but I believe that Aviva shares remain undervalued and could deliver significant gains in the next 6-12 months.

Undervalued

Aviva is still trading at a significant discount to its peers, suggesting that markets have not yet priced in a successful turnaround. Aviva currently trades on a 2013 forecast P/E of 9.7, compared to 10.6 for RSA Insurance Group and 14.5 for Prudential.

Using analysts’ consensus forecasts for 2013 earnings of 42.9p per share, and a forecast P/E of 11, would give Aviva a share price of 471p — a 13% gain on today’s price.

I think this is a reasonable valuation, and I reckon that two events later this year could help trigger this re-rating.

Leaving the US

A key element of Aviva’s turnaround plan is the sale of the group’s US business.

Aviva has agreed a $1.8bn deal with private equity house Apollo Global Management, but regulatory issues have delayed progress and have forced Apollo to agree to special conditions, in order to get the deal approved by US regulators.

Things now seem to be moving again, and Aviva’s interim results in August confirmed that the sale of the US business is expected to complete by the end of the year. I believe that the removal of the uncertainty relating to this deal could trigger further gains for Aviva shares.

Dividend blues

Aviva’s 44% dividend cut went down like a lead balloon when it was announced in March, and the firm has since cut its interim payout by the same amount, giving Aviva shares a trailing yield of about 3.5%.

In my view, a return to progressive dividend increases could be the final trigger for the re-rating of Aviva’s shares. The question for investors is whether a modest increase to the final dividend will be possible this year.

Analysts’ consensus forecasts are indicating a full-year dividend of 15.6p, which implies an increase of 1p — or 11% — to last year’s 9p final dividend, taking the prospective yield to a reasonable 3.8%.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Roland owns shares in Aviva but does not own shares in any of the other companies mentioned in this article.

More on Investing Articles

Investing Articles

1 FTSE dividend stock I’d put 100% of my money into for passive income!

If I could invest in just one stock to generate a regular passive income stream, I'd choose this FTSE 100…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

Forecasts are down, but I see a bright future for FTSE 100 dividend stocks

Cash forecasts for UK dividend stocks are falling... time to panic! Actually, no. I reckon the future has never looked…

Read more »

Young female analyst working at her desk in the office
Investing Articles

Down 13% in April, AIM stock YouGov now looks like a top-notch bargain

YouGov is an AIM stock that has fallen into potential bargain territory. Its vast quantity of data sets it up…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Beating the S&P 500? I’d buy this FTSE 250 stock for my Stocks and Shares ISA

Beating the S&P 500's tricky, but Paul Summers is optimistic on this FTSE 250 stock's ability to deliver based on…

Read more »

Passive and Active: text from letters of the wooden alphabet on a green chalk board
Investing Articles

2 spectacular passive income stocks I’d feel confident going all in on

While it's true that diversification is key when it comes to safe and reliable investing, these two passive income stocks…

Read more »

Investing Articles

The easyJet share price is taking off. I think it could soar!

The easyJet share price is having a very good day. Paul Summers takes a look at the latest trading update…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

9 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

As the Rentokil share price dips on Q1 news, I ask if it’s time to buy

The Rentokil Initial share price has disappointed investors in the past 12 months. Could this be the year we get…

Read more »